Pan-Cancer Analysis for Identification of Tumor Antigens and Immune Subtypes in mRNA Vaccine Development. iCell, [S. l.], v. 1, n. 1, 2024. DOI: 10.71373/FEHU5094. Disponível em: https://www.icelljoural.com/index.php/iCell/article/view/5. Acesso em: 6 may. 2025.